# A Study of LY3015014 in Participants With High Cholesterol

> **NCT01890967** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 527 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** LY3015014
- **DRUG:** Placebo
- **DRUG:** Statin
- **DRUG:** Ezetimibe

## Key facts

- **NCT ID:** NCT01890967
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-04
- **Final completion:** 2014-06
- **Target enrollment:** 527 (ACTUAL)
- **Last updated:** 2019-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01890967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01890967, "A Study of LY3015014 in Participants With High Cholesterol". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01890967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*